IRIDEX Corporation (NASDAQ:IRIX) shares fell to a low of $4.94 before closing at $5.16. Intraday shares traded counted 73218.0, which was 85.54% higher than its 30-day average trading volume of 506.20K. IRIX’s previous close was $5.20 while the outstanding shares total 13.89M. The firm has a beta of 1.11. The stock’s Relative Strength Index (RSI) is 59.48, with weekly volatility at 12.78% and ATR at 0.62. The IRIX stock’s 52-week price range has touched low of $1.22 and a $6.25 high. The stock traded lower over the last trading session, losing -0.77% on 02/11/21.
Investors have identified the Medical Devices company IRIDEX Corporation as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $72.24 million, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
IRIDEX Corporation (IRIX) Fundamentals that are to be considered.
When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. For IRIX, the company has in raw cash 11.93 million on their books with 1.53 million currently as liabilities. How the trend is over time is what investors should be concerned about. The company has a healthy balance sheet as their debt profile has been on an incline. In terms of their assets, the company currently has 25.56 million total, with 9.21 million as their total liabilities.
Having a look at the company’s valuation, the company is expected to record -0.34 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on IRIX sounds very interesting.
Is the stock of IRIX attractive?
In related news, Director, Grove Robert Earle bought 15,125 shares of the company’s stock in a transaction that recorded on May 15. The purchase was performed at an average price of 1.68, for a total value of 25,446. In the last 6 months, insiders have changed their ownership in shares of company stock by 0.80%.
2 out of 2 analysts covering the stock have rated it a Buy, while 0 have maintained a Hold recommendation on IRIDEX Corporation. 0 analysts has assigned a Sell rating on the IRIX stock. The 12-month mean consensus price target for the company’s shares has been set at $6.50.